At its second virtual meeting of 2026, the ENCePP Steering Group (SG) endorsed a proposal from EMA to extend the current SG mandate by an additional year, until the end of 2027. This extension supports efficiency and continuity in leadership, and will support completion of the 2024-2026 workplan and delivery of all objectives of the Working Groups and Special Interest Groups. It will also enable continued reflection on ENCePP’s future direction, building on the experience of the SG.
Minutes of the ENCePP Steering Group, 30 April 2026
Details
- Publication date
- 21 May 2026
- Author
- European Medicines Agency